cbdMD, Inc. Quarterly Cost of Revenue in USD from Q4 2016 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
cbdMD, Inc. quarterly/annual Cost of Revenue history and growth rate from Q4 2016 to Q4 2024.
  • cbdMD, Inc. Cost of Revenue for the quarter ending December 31, 2024 was $1.71M, a 5.78% decline year-over-year.
  • cbdMD, Inc. Cost of Revenue for the twelve months ending December 31, 2024 was $7.38M, a 12.9% decline year-over-year.
  • cbdMD, Inc. annual Cost of Revenue for 2024 was $7.49M, a 18.4% decline from 2023.
  • cbdMD, Inc. annual Cost of Revenue for 2023 was $9.18M, a 29.8% decline from 2022.
  • cbdMD, Inc. annual Cost of Revenue for 2022 was $13.1M, a 9.86% decline from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $7.38M $1.71M -$105K -5.78% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-13
Q3 2024 $7.49M $2.1M -$59.3K -2.75% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-18
Q2 2024 $7.55M $1.77M -$503K -22.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $8.05M $1.8M -$429K -19.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $8.48M $1.82M -$700K -27.8% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-13
Q3 2023 $9.18M $2.16M -$730K -25.2% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-18
Q2 2023 $9.91M $2.27M -$386K -14.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $10.3M $2.22M -$962K -30.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $11.3M $2.52M -$1.81M -41.8% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $13.1M $2.89M -$1.16M -28.6% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-22
Q2 2022 $14.2M $2.66M -$711K -21.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $14.9M $3.19M -$457K -12.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $15.4M $4.33M +$898K +26.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 $14.5M $4.05M -$1.28M -24.1% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-15
Q2 2021 $15.8M $3.37M -$377K -10.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $16.2M $3.64M +$911K +33.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $15.2M $3.43M -$270K -7.3% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 $15.5M $5.33M +$1.21M +29.2% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-17
Q2 2020 $14.3M $3.75M +$819K +28% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $13.5M $2.73M +$817K +42.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $12.7M $3.7M +$3.54M +2136% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $9.14M $4.13M +$5.88M Jul 1, 2019 Sep 30, 2019 10-K 2020-12-22
Q2 2019 $3.25M $2.93M +$1.82M +165% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.43M $1.91M +$1.39M +266% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $41.4K $165K -$62.6K -27.5% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 $104K -$1.75M -$2.29M -429% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-18
Q2 2018 $2.39M $1.11M +$845K +323% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.55M $524K +$125K +31.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $1.42M $228K +$65.4K +40.2% Oct 1, 2017 Dec 31, 2017 10-Q/A 2019-04-26
Q3 2017 $1.36M $533K Jul 1, 2017 Sep 30, 2017 10-K 2018-12-12
Q2 2017 $261K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $398K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $163K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.